This content requires a premium subscription.
Please log in or subscribe to continue.
JACC Specialty Journals
JACC: CardioOncology - Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2+ Breast Cancer Therapy
Released: Dec 21, 2021
Commentary by Dr. Daniel Zllotoff
JACC: CardioOncology - Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2+ Breast Cancer Therapy